Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: United States Clear all

586 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
20017
200211
200318
200415
200520
200626
200723
200818
200921
201042
201129
201225
201313
201416
201520
201635
201731
201820
201929
202017
202117
202229
202322
202414
202519
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed318
Terminated96
Active, not recruiting66
Recruiting61
Unknown status26
Withdrawn13
Suspended3
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)78
Gynecologic Oncology Group36
M.D. Anderson Cancer Center36
Memorial Sloan Kettering Cancer Center28
Dana-Farber Cancer Institute15
Mayo Clinic15
Roswell Park Cancer Institute15
Masonic Cancer Center, University of Minnesota12
AbbVie8
University of Washington8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms586
Ovarian Neoplasms472
Carcinoma, Ovarian Epithelial199
Endometrial Neoplasms85
Breast Neoplasms53
Uterine Cervical Neoplasms53
Neoplasms46
Peritoneal Neoplasms37
Brenner Tumor34
Carcinoma, Non-Small-Cell Lung32

Trials

Showing 51 to 75 of 586. Each trial links to its page on Pharma Observatory.

486 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.